Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mitochondrial DNA A DNA Mapp Seq Anal ; 27(4): 2864-7, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-26114318

RESUMEN

The genetic diagnosis algorithm for mitochondrial (mt) diseases starts looking for deletions and common mutations in mtDNA. MtDNA's special features, such as large and variable genome copies, heteroplasmy, polymorphisms, and its duplication in the nuclear genome as pseudogenes (NUMTs), make it vulnerable to diagnostic misleading interpretations. Multiplex Ligation-dependent Probe Amplification (MLPA) is used to detect copy number variations in nuclear genes and its application on mtDNA has not been widely spread. We report three Kearns Sayre Syndrome patients and one Chronic Progressive External Ophthalmoplegia adult, whose diagnostic mtDNA deletions were detected by MLPA using a very low amount of DNA. This managed to "dilute" the NUMT interference as well as enhance MLPA's efficiency. By this report, we conclude that when MLPA is performed upon a reduced amount of DNA, it can detect effectively mtDNA deletions. We propose MLPA as a possible first step method in the diagnosis of mt diseases.


Asunto(s)
ADN Mitocondrial/genética , Genoma Mitocondrial/genética , Reacción en Cadena de la Polimerasa Multiplex/métodos , Algoritmos , Variaciones en el Número de Copia de ADN/genética , Humanos , Síndrome de Kearns-Sayre/genética , Enfermedades Mitocondriales/genética
2.
Arch Argent Pediatr ; 108(1): e13-6, 2010 Feb.
Artículo en Español | MEDLINE | ID: mdl-20204226

RESUMEN

In August 2008, the province of Buenos Aires had not adhered to the National law number 26279, that establishes the obligatory nature of the neonatal screening for biotinidase deficiency, among other diseases. In that date, a girl was born in Buenos Aires. She was admitted in the Hospital "J. P. Garrahan" with lethargy, metabolic acidosis, hiperlactacidemia, alopecia, conjuntivitis and scaly erythematous eruption in trunk, at 58 days of life, from a pediatric intensive care unit. Due to this clinic (13 days of evolution), a biotinidase assay in serum was done. This was abnormally low. She initiates treatment with biotin and the biochemical abnormalities revert quickly. If the neonatal screening had been done, this girl wouldn't have been exposed at risk of death, and a normal development would have been assure (by the presymptomatic beginning of the treatment), since the neurological injuries not always go back ad integrum.


Asunto(s)
Deficiencia de Biotinidasa/diagnóstico , Tamizaje Neonatal/legislación & jurisprudencia , Argentina , Femenino , Humanos , Lactante , Recién Nacido , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA